Skip to main content

Table 1 Patient characteristics.

From: Pretreatment thrombocytosis as an independent predictive factor for chemoresistance and poor survival in epithelial ovarian cancer

Characteristics

 

No. (n = 280)

Age (years)

Mean ± SD

56.7 ± 11.9

Platelet counts (× 103/ mm3)

 ≥ 400 

53 (18.9%)

  <  400

227 (81.1%)

Hb (g/ dl)

Mean ± SD

11.8 ± 1.5

Microcytic hypochromic anemia

 Present

23 (8.2%)

 Absent

259 (91.8%)

Primary treatment

 PDS

207 (73.9%)

 NAC

73 (26.1%)

FIGO stage

 I

91 (32.5%)

 II

39 (13.9%)

 III

110 (39.3%)

 IV

40 (14.3%)

Histologic subtype

 Serous

105 (37.5%)

 Clear cell

83 (29.6%)

 Others*

92 (32.9%)

Operation achievement

 Complete

206 (73.6%)

 Optimal

56 (20.0%)

 Suboptimal

18 (6.4%)

Nonmalignant inflammatory condition

 Present

15 (5.4%)

 Absent

265 (94.6%)

CA125 (U/ mL)

Mean ± SD

1591 ± 3618

  1. *Endometrioid, mucinous, undifferentiated, or mixed type. Abbreviations: SD standard deviation, Hb hemoglobin, PDS primary debulking surgery, NAC neoadjuvant chemotherapy, FIGO International Federation of Gynecology and Obstetrics